Søren S. Lund

Pooled analysis of Phase III trials indicate contrasting influences of renal function on blood pressure, body weight, and HbA1c reductions with empagliflozin

David Z.I. Cherney, Mark E. Cooper, Ilkka Tikkanen et al. · Kidney International · 2017 · 245 citations · Full text

Medicine, Nephrology, Pharmacology +11

The effect of sodium glucose cotransporter 2 inhibition with empagliflozin on microalbuminuria and macroalbuminuria in patients with type 2 diabetes

David Z.I. Cherney, Søren S. Lund, Bruce A. Perkins et al. · Diabetologia · 2016 · 172 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Empagliflozin reduces body weight and indices of adipose distribution in patients with type 2 diabetes mellitus

Ian J. Neeland, Darren K. McGuire, Robert Ćhilton et al. · Diabetes and Vascular Disease Research · 2015 · 165 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Effects of 12 weeks of treatment with fermented milk on blood pressure, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: a randomised double-blind placebo-controlled study

Karin D. Hove, Charlotte Brøns, Kristine Færch et al. · European Journal of Endocrinology · 2014 · 110 citations

Agriculture, Nutrition, Nutritional Sciences +17

Effect of empagliflozin monotherapy on postprandial glucose and 24-hour glucose variability in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, 4-week study

Rimei Nishimura, Yuko Tanaka, Kazuki Koiwai et al. · Cardiovascular Diabetology · 2015 · 104 citations · Full text

Medicine, Endocrinology, Pharmacology +15